ZY

Zydus Wellness LtdNSE ZYDUSWELL Stock Report

Last reporting period 31 Mar, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.755

Micro

Exchange

XNSE - National Stock Exchange Of India

ZYDUSWELL.NS Stock Analysis

ZY

Neutral

Based on Eyestock quantitative analysis, ZYDUSWELL.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

50/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-14.3 %

Overvalued

Market cap $B

0.755

Dividend yield

0.47 %

Shares outstanding

63.632 B

Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. The company is headquartered in Ahmedabad, Gujarat and currently employs 975 full-time employees. The firm operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company’s product portfolio includes brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.

View Section: Eyestock Rating